B3GALT2 rs6661798: What Your Genotype Means
The rs6661798 variant is a single nucleotide polymorphism located within the B3GALT2 gene region. It has been identified in genetic research as a marker potentially associated with altered susceptibility to age-related macular degeneration.
What each genotype means
Typical risk baseline
You carry two copies of the common C allele at rs6661798. Large genome-wide association meta-analyses indicate that this baseline genotype is not associated with the modestly altered susceptibility to age-related macular degeneration observed with the minor T allele. Because evidence for this locus remains limited, overall vision health depends primarily on well-established genetic loci, age, and lifestyle factors.
Carried by approximately 60% to 65% of individuals of European ancestry and the majority of non-European populations.
Modestly altered AMD risk
You carry one copy of the minor T allele at rs6661798 near the B3GALT2 gene. In genome-wide meta-analyses of age-related macular degeneration, this allele is linked to a small shift in statistical disease susceptibility, though evidence remains limited and is largely derived from European cohorts. This single variant confers only a minimal effect and does not diagnose or predict macular degeneration.
Carried by approximately 30% to 35% of people of European ancestry; less common in African and East Asian populations.
Altered AMD risk profile
You carry two copies of the minor T allele at rs6661798 in the B3GALT2 region. Published genome-wide association studies show that having two copies is associated with a modest statistical alteration in age-related macular degeneration risk. The biological mechanism and clinical effect of this locus remain limited in scope, and carrying this genotype does not mean you will develop vision loss.
Carried by approximately 3% to 5% of individuals of European ancestry and rarely found in East Asian cohorts.
Understanding the rs6661798 Variant
A single nucleotide polymorphism, or SNP, is a variation at a single position in a DNA sequence among individuals. The variant rs6661798 represents a specific location in the human genome where different individuals may carry different nucleotides. This SNP is situated in the genomic region associated with the B3GALT2 gene. In the context of genetic research, scientists use such markers to investigate how variations in our DNA might correlate with specific health traits or conditions. Because the human genome is vast, these markers act like signposts that help researchers narrow down areas of interest that may influence biological processes. It is important to note that the presence of a specific SNP does not determine a health outcome on its own, but rather serves as a statistical point of interest in large-scale population studies.
The Role of the B3GALT2 Gene
The B3GALT2 gene encodes a protein known as beta-1,3-galactosyltransferase 2. This enzyme plays a role in the glycosylation process, which involves adding sugar molecules to proteins or lipids. Glycosylation is a fundamental biological mechanism that affects how proteins fold, function, and interact within the body. While the exact functional impact of the rs6661798 variant on the B3GALT2 protein remains a subject of ongoing investigation, researchers study this gene to understand its potential influence on cellular health. Variations in genes involved in complex biochemical pathways are often scrutinized in genome-wide association studies to see if they contribute to the development of chronic conditions. Currently, the evidence linking this specific gene to clinical outcomes is considered limited, and further research is required to fully elucidate its biological significance in human health.
Research and Evidence Strength
The association between rs6661798 and age-related macular degeneration (AMD) has been noted in the context of genetic research, specifically within the GWAS Catalog. AMD is a condition that affects the macula, the part of the eye responsible for sharp central vision. While large-scale studies have identified numerous genetic loci associated with AMD, the evidence for any single variant can vary in strength. The association for rs6661798 is currently categorized as having limited evidence. This means that while statistical signals have been observed in certain cohorts, these findings may not be consistent across all populations or study designs. Genetic associations are often complex, involving multiple genes and environmental factors. Therefore, this variant should be viewed as a small piece of a much larger, ongoing scientific puzzle rather than a definitive diagnostic tool for eye health.
Interpreting Your Genetic Information
When reviewing genetic data, it is essential to understand that a single SNP rarely provides a complete picture of health. The information regarding rs6661798 is intended for educational purposes and should not be used to make medical decisions or self-diagnose. If you are concerned about your vision or have a family history of age-related macular degeneration, the most effective step is to consult with an eye care professional, such as an ophthalmologist or optometrist. They can provide comprehensive screenings and personalized advice based on your clinical history and current eye health. Genetic markers are tools for researchers to understand disease mechanisms at a population level, but they do not replace the value of clinical examinations and professional medical guidance. Always discuss any health concerns with a qualified healthcare provider who can interpret your specific situation in the context of your overall well-being.
How common is this variant?
The minor allele frequency for rs6661798 is approximately 20% in European cohorts, making it a relatively common variant in those populations.
Frequently asked questions
What is rs6661798?
rs6661798 is a single nucleotide polymorphism (SNP) located in the B3GALT2 gene region. It is a genetic marker that has been studied for its potential association with age-related macular degeneration.
Does this variant cause macular degeneration?
No, this variant does not cause macular degeneration. It is simply a genetic marker that has shown a statistical association with the condition in some research studies, but it is not a definitive cause.
How common is the rs6661798 variant?
The minor allele frequency for this variant is approximately 20% in European populations. This means it is a relatively common genetic variation in those groups.
Should I be worried if I have the GG genotype?
No, you should not be worried. Genetic associations are complex and often involve many factors. This information is for educational purposes and should not be used to assess your personal health risk.
What should I do if I am concerned about my eye health?
If you have concerns about your vision or eye health, you should schedule an appointment with an eye care professional. They can perform a clinical exam, which is the best way to assess your eye health.
Sources & further reading
Educational information only, last refreshed 10/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6661798?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29